Abstract
Background
The VASOGRADE is a simple aneurysmal subarachnoid hemorrhage (aSAH) grading scale that combines the modified Fisher scale (mFisher) and the World Federation of Neurological Societies (WFNS) grading system, allowing the stratification of delayed cerebral ischemia (DCI) risk. However, the VASOGRADE accuracy in predicting functional outcomes is still to be determined.
Methods
We retrospectively evaluated a multiethnic cohort of consecutive patients with aSAH admitted to a high-volume center in Brazil from January 2016 to January 2019. Patients were classified according to the severity of the clinical presentation (WFNS), the amount of blood in the initial head computerized tomography (mFisher) scan, and the VASOGRADE (green, yellow, red). The primary outcome was to detect DCI-related cerebral infarction, and the secondary outcome was the functional outcome at hospital discharge according to the modified Rankin scale (mRs). Univariate and multivariate logistic regression models were employed.
Results
A total of 212 patients (71.7% female, mean age 52.7 ± 12.8) were included. Sixty-nine patients were classified as VASOGRADE-Green (32.5%), 98 patients as VASOGRADE-Yellow (46.9%), and 45 patients as VASOGRADE-Red (20.6%). DCI-related infarction was present in 39 patients (18.9%). The proportions of patients in the VASOGRADE-Green, VASOGRADE-Yellow, and VASOGRADE-Red categories with DCI-related infarction were 7.7, 61.5, and 30.8%, respectively. After a multivariable analysis including age, sex, aneurysm location, and the VASOGRADE classification as variables, both VASOGRADE-Yellow and VASOGRADE-Red were independently associated with DCI-related infarction (odds ratio [OR] 7.69, 95% confidence interval [CI] 2.13–27.8, and OR 8.07, 95% CI 2.03–32.11, respectively) and unfavorable outcome (OR 4.16, 95% CI 1.33–13.03, and OR 25.57, 95% CI 4.45–147.1, respectively). The VASOGRADE discrimination performance for DCI-related infarction (area under the receiver operating characteristic curve) was 0.67 ± 0.04 (95% CI 0.58–0.75; p = 0.001). VASOGRADE-Red had 97.5% specificity for predicting an unfavorable mRs score at discharge (95% CI 92.8–99.5%). Conversely, VASOGRADE-Green had an excellent specificity for predicting favorable outcome at discharge (mRs score 0–2, 95% CI 82.6–95.5%).
Conclusions
In conclusion, in a multiethnic cohort of patients with aSAH, VASOGRADE-Green predicted the absence of DCI and good clinical outcome at discharge with very high specificity, and patients in this category might be selected for early intensive care unit (ICU) discharge, minimizing costs and medical complications associated with prolonged hospital stay. On the other hand, patients categorized as VASOGRADE-Yellow and VASOGRADE-Red were at the highest risk for DCI. They should, therefore, be selected as a priority for care in high-volume aSAH centers, being aggressively monitored for DCI at the ICU. Such stratification methods are crucial, especially in countries with low financial resources and high health care services demand.
Similar content being viewed by others
References
Shea AM, Reed SD, Curtis LH, Alexander MJ, Villani JJ, Schulman KA. Characteristics Of Nontraumatic Subarachnoid Hemorrhage In The United States In 2003. Neurosurgery. 2007;61(6):1131–8.
Perry JJ, Stiell IG, Sivilotti MLA, Bullard MJ, Hohl CM, Sutherland J, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA - J Am Med Assoc. 2013;310(12):1248–55.
de Rooij NK, Greving JP, Rinkel GJE, Frijns CJM. Early prediction of delayed cerebral ischemia after subarachnoid hemorrhage: development and validation of a practical risk chart. Stroke. 2013;44(5):1288–94.
de Oliveira Manoel AL, Goffi A, Marotta TR, Schweizer TA, Abrahamson S, Macdonald RL. The critical care management of poor-grade subarachnoid haemorrhage. Crit Care BioMed Central Ltd. 2016. https://doi.org/10.1186/s13054-016-1193-9.
Rouanet C, Chaddad F, Freitas F, Miranda M, Vasconcellos N, Valiente R, et al. Kinetics of cerebral blood flow velocities during treatment for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2022;36(1):226–39.
Francoeur CL, Mayer SA. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care BioMed Central Ltd. 2016. https://doi.org/10.1186/s13054-016-1447-6.
Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10:44–58.
Diringer MN, Bleck TP, Hemphill JC, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: Recommendations from the neurocritical care society’s multidisciplinary consensus conference. Neurocrit Care. 2011;15:211–40.
Vergouwen MDI, Vermeulen M, van Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke; J Cereb Circ. 2010;41(10):2391–5.
Crobeddu E, Mittal MK, Dupont S, Wijdicks FM, Lanzino G, et al. Predicting the lack of development of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke. 2011. https://doi.org/10.1161/STROKEAHA.111.
de Oliveira Manoel AL, Jaja BN, Germans MR, Yan H, Qian W, Kouzmina E, et al. The vasograde. Stroke. 2015;46(7):1826–31.
Collins GS, Ogundimu EO, Altman DG. Sample size considerations for the external validation of a multivariable prognostic model: a resampling study. Stat Med. 2016;35(2):214–26.
Greving JP, Wermer MJH, Brown RD, Morita A, Juvela S, Yonekura M, et al. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol. 2014;13(1):59–66.
Lannes M, Teitelbaum J, del Pilar CM, Cardoso M, Angle M. Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the montreal neurological hospital protocol. Neurocrit Care. 2012;16(3):354–62.
Dumont TM, Rughani AI, Tranmer BI. Prediction of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage with an artificial neural network: feasibility and comparison with logistic regression models. World Neurosurg. 2011;75(1):57–63.
Gonzalez NR, Boscardin WJ, Glenn T, Vinuela F, Martin NA. Vasospasm probability index: a combination of transcranial Doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2007;107(6):1101–12.
Rosen DS, Loch Macdonald R. Subarachnoid hemorrhage grading scales: a systematic review. Neurocrit Care. 2005;2(2):110–8.
Modi S, Shah K, Schultz L, Tahir R, Affan M, Varelas P. Cost of hospitalization for aneurysmal subarachnoid hemorrhage in the United States. Clin Neurol Neurosurg. 2019;182:167–70.
Torbey MT, Hauser TK, Bhardwaj A, Williams MA, Ulatowski JA, Mirski MA, et al. Effect of age on cerebral blood flow velocity and incidence of vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2001;32(9):2005–11.
Magge SN, Chen HI, Ramakrishna R, Cen L, Chen Z, Elliott JP, et al. Association of a younger age with an increased risk of angiographic and symptomatic vasospasms following subarachnoid hemorrhage. J Neurosurg. 2010;112(6):1208–15.
Eagles ME, Jaja BNR, Macdonald RL. Incorporating a modified graeb score to the modified fisher scale for improved risk prediction of delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage. Neurosurgery. 2018;82(3):299–305.
Kassell NF, Torner JC, Haley EC, Jane JA, Adams HP, Kongable GL, et al. The international cooperative studyon the timing of aneurysm surgery. J Neurosurg. 1990;73(1):18–36.
Mees SMD, Kerr RS, Rinkel GJE, Algra A, Molyneux AJ. Occurrence and impact of delayed cerebral ischemia after coiling and after clipping in the International Subarachnoid Aneurysm Trial (ISAT). J Neurol. 2012;259(4):679–83.
Molyneux AJ, Birks J, Clarke A, Sneade M, Kerr RSC. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet. 2015;385(9969):691–7.
Buscot MJ, Chandra RV, Maingard J, Nichols L, Blizzard L, Stirling C, et al. Association of onset-to-treatment time with discharge destination, mortality, and complications among patients with aneurysmal subarachnoid hemorrhage. JAMA Netw Open. 2022;5(1):e2144039. https://doi.org/10.1001/jamanetworkopen.2021.44039.
Acknowledgements
The present work was conducted with the support of the National Council for Scientific and Technological Development–Brazil.
Funding
No funding was required.
Author information
Authors and Affiliations
Contributions
NVOS: was responsible for conception, organization, and execution of the case report project and writing of the first draft of the manuscript, and review and critique of the manuscript. CR: was responsible for organization and execution of the case report project and writing of the first draft of the manuscript. DJFS: was responsible for organization and execution of the case report project and review and critique of the manuscript. CVBL: was responsible for organization and execution of the case report project and review and critique of the manuscript. CAS: was responsible for organization and execution of the case report project and review and critique of the manuscript. FR: was responsible for conception of the case report project and review and critique of the manuscript. MMA: was responsible for conception of the case report project and review and critique of the manuscript. ALOM: was responsible for organization and execution of the case report project and review and critique of the manuscript. FCN: was responsible for conception of the case report project and review and critique of the manuscript. MF: was responsible for conception of the case report project and review and critique of the manuscript. GSS: was responsible for conception, organization, and execution of the case report project, writing of the first draft of the manuscript, and review and critique of the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
All authors declare no conflicts of interest.
Ethical approval/informed consent
Full consent was obtained from the patients and/or family members, and this study was approved by the Ethical Committee of São Paulo Hospital, in accordance with the ethical standards as laid out in the 1964 Declaration of Helsinki and its later amendments.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Oliveira Souza, N.V., Rouanet, C., Solla, D.J.F. et al. The Role of VASOGRADE as a Simple Grading Scale to Predict Delayed Cerebral Ischemia and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care 38, 96–104 (2023). https://doi.org/10.1007/s12028-022-01577-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-022-01577-1